Levels of asymmetric dimethylarginine (ADMA) are increased in women that subsequently develop preeclampsia and whose children develop intrauterine-growth restriction (IUGR)

摘要

A method of identifying whether or not a pregnant woman is at risk of developing pre-eclampsia or whether or not her fetus is at risk of developing intrauterine growth restriction (IUGR). The method comprises: a) measuring asymmetric dimethlarginine (ADMA) in a pregnant women at a stage of her pregnancy from 4-25 weeks gestation; and b) determining whether or not the ADMA is greater than 2.0_mol/L in the woman, thereby determining whether or not the woman is at risk of developing pre-eclampsia or her fetus is at risk of developing IUGR.